DIN 02145766 — VISIPAQUE 270 550 MG
VISIPAQUE 270 is a solution of Iodixanol marketed by GE HEALTHCARE CANADA INC. The full Iodixanol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02145766
- Brand name
- VISIPAQUE 270
- Active ingredient
- Iodixanol
- Strength
- 550 MG
- Dosage form
- SOLUTION
- Route
- INTRA-ARTERIAL; INTRAVENOUS
- Manufacturer
- GE HEALTHCARE CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Non-ionic iodinated radiographic contrast medium
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Iodixanol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02553953 | IODIXANOL INJECTION 270 | 550 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02553961 | IODIXANOL INJECTION 320 | 652 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02145774 | VISIPAQUE 320 | 652 MG | SOLUTION | GE HEALTHCARE CANADA INC | MARKETED |